Signum Life Science ApS: Financial statements 2020
CVR: 36559241
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Signum Life Science ApS (CVR 36559241) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 8,099,776 and a net result of DKK 1,046,195 compared with DKK 3,795,326 the year before. That is a decrease of 22.5% compared with the year before. Equity in the 2020 report amounted to DKK 128,191,993. The solvency ratio was 81.1%. The company had 32 employees in the financial year.
- Gross Profit
- DKK 8,099,776
- Profit/Loss
- DKK 1,046,195
- Equity
- DKK 128,191,993
- Total Assets
- DKK 157,991,729
- Employees
- 32
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 8.1M | 1M | 128.2M | 32 |
| 2019 | - | 10.5M | 3.8M | 129.2M | 28 |
| 2018 | - | 12M | 4.1M | 127.5M | 21 |
| 2017 | - | 12.5M | 5.5M | 125.8M | - |
| 2016 | - | 11.4M | 4.8M | 122.5M | 16 |
Official annual report
How creditworthy is Signum Life Science ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of May 15, 2020, Thomas Bo Bjørn Klee has joined the board of directors of Signum Life Science ApS.
As of May 15, 2020, Lars Møller has joined the board of directors of Signum Life Science ApS.
As of May 15, 2020, Andreas Daugaard Jørgensen has joined the board of directors of Signum Life Science ApS.
As of May 14, 2020, Thomas Bo Bjørn Klee has left the board of directors of Signum Life Science ApS.
As of May 14, 2020, Lars Møller has left the board of directors of Signum Life Science ApS.
As of May 14, 2020, Andreas Daugaard Jørgensen has left the board of directors of Signum Life Science ApS.
Signum Life Science ApS has published its annual report for 2019. Gross profit came to DKK 10,457,442, and the net result was DKK 3,795,326.
As of March 30, 2020, Allan Karne Levisen has joined the board of directors of Signum Life Science ApS.
As of March 30, 2020, Cecilie Betzer has left the board of directors of Signum Life Science ApS.
As of March 29, 2020, Allan Karne Levisen has left the board of directors of Signum Life Science ApS.
About Signum Life Science ApS
Signum Life Science ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2015. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named DLI Market Intelligence ApS. The management consists of Thomas Senderovitz. The board consists of Anja Cecilie Verhaug (chair), Mari-Ann Retz, Anne Marie Hedegaard Byskov and Søren Hvidsten Nielsen. The company is owned by DLI - DANSK LÆGEMIDDEL INFORMATION A/S and TJELLESEN MAX JENNE A/S. The company has 53 employees (2026). In 2025, the company reported a gross profit of DKK -67,441,461 and a net result of DKK -66,049,966 compared with DKK -5,936,982 the year before. Equity in the 2025 report amounted to DKK 40,680,589.
